Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | LMNA | P02545 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 4/20 | 0.44 |
| ▸ | RAB9A | P51151 | 4/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3156328 | 0.91 | LMNA (0.55) | MEN1KMT2ALMNAALDH1A1POLB | |
| SCHEMBL28935780 | 0.85 | CES2 (0.49) | MEN1KMT2ALMNAALDH1A1POLB | |
| SCHEMBL10277192 | 0.85 | KMT2A (0.43) | MEN1KMT2ALMNAALDH1A1POLB | |
| SCHEMBL27025554 | 0.83 | ALDH1A1 (0.46) | MEN1KMT2ALMNAALDH1A1POLB | |
| SCHEMBL58133 | 0.83 | CES2 (0.47) | MEN1KMT2ALMNAALDH1A1POLB | |
| SCHEMBL16332806 | 0.80 | RARB (0.50) | MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL28935802 | 0.79 | CES2 (0.49) | MEN1KMT2ALMNAALDH1A1NPC1 | |
| SCHEMBL36028 | 0.79 | LMNA (0.48) | MEN1KMT2ALMNAALDH1A1POLB | |
| SCHEMBL30954339 | 0.79 | ALDH1A1 (0.48) | MEN1KMT2ALMNAALDH1A1POLB | |
| SCHEMBL7624661 | 0.79 | ALDH1A1 (0.50) | MEN1KMT2ALMNAALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115611940-A | Method for preparing acylphosphine oxide photoinitiator and co-producing substituted oxetane compounds | 常州强力先端电子材料有限公司 | 2023-01-17 | — | — | CN | disclosed |
| US-20120019938-A1 | CURABLE RESIN COMPOSITION FOR CEMENTED LENS, IMAGING LENS, AND METHOD FOR MANUFACTURING IMAGING LENS | FUJIFILM CORPORATION (JP) | 2012-01-26 | — | — | US | disclosed |
| US-20120019938-A1 | CURABLE RESIN COMPOSITION FOR CEMENTED LENS, IMAGING LENS, AND METHOD FOR MANUFACTURING IMAGING LENS | FUJIFILM CORPORATION (JP) | 2012-01-26 | — | — | US | disclosed |
| US-20090297955-A1 | OPTICAL RECORDING COMPOSITION, HOLOGRAPHIC RECORDING MEDIUM, AND METHOD OF RECORDING AND REPRODUCING INFORMATION | FUJIFILM CORPORATION (JP) | 2009-12-03 | — | — | US | disclosed |
| US-20090297955-A1 | OPTICAL RECORDING COMPOSITION, HOLOGRAPHIC RECORDING MEDIUM, AND METHOD OF RECORDING AND REPRODUCING INFORMATION | FUJIFILM CORPORATION (JP) | 2009-12-03 | — | — | US | disclosed |
| US-20090202920-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-08-13 | — | — | US | disclosed |
| US-20090202920-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-08-13 | — | — | US | disclosed |
| US-20090202921-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-08-13 | — | — | US | disclosed |
| US-20090202921-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-08-13 | — | — | US | disclosed |
| US-20090170009-A1 | HOLOGRAPHIC RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-07-02 | — | — | US | disclosed |
| US-20090170009-A1 | HOLOGRAPHIC RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-07-02 | — | — | US | disclosed |
| US-20090170008-A1 | HOLOGRAPHIC RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-07-02 | — | — | US | disclosed |
| US-20090170008-A1 | HOLOGRAPHIC RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-07-02 | — | — | US | disclosed |
| US-20090142672-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-06-04 | — | — | US | disclosed |
| US-20090142672-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-06-04 | — | — | US | disclosed |
| US-20090142671-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-06-04 | — | — | US | disclosed |
| US-20090142671-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090202921-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | CHRNA6, NR2E3, NR4A1 | MEN1 2739/4885KMT2A 2284/4885LMNA 3261/4885 |
| US-20090170009-A1 | HOLOGRAPHIC RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | KAT2B, H1-0, RPLP2 | MEN1 3341/4885KMT2A 1633/4885LMNA 1223/4885 |
| US-20090202920-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | CHAT, HCN2, HCN1 | MEN1 2397/4885KMT2A 1143/4885LMNA 1653/4885 |
| US-20090142671-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | CACNA1S, CACNA1E, CRY1 | MEN1 1298/4885KMT2A 1072/4885LMNA 3174/4885 |
| US-20090142672-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | CRY1, CRY2, CACNA1B | MEN1 2658/4885KMT2A 1407/4885LMNA 2219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.